FUNCTION OF DIPEPTIDYL PEPTIDASE-IV (CD26, TP103) IN TRANSFECTED HUMAN T-CELLS

被引:33
作者
HEGEN, M
CAMERINI, D
FLEISCHER, B
机构
[1] UNIV MAINZ,DEPT MED 1,LANGENBECKSTR 1,W-6500 MAINZ,GERMANY
[2] MASSACHUSETTS GEN HOSP,DEPT MOLEC BIOL,BOSTON,MA 02114
关键词
D O I
10.1006/cimm.1993.1024
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD26 (Tp103) is a proteolytic enzyme (dipeptidyl peptidase IV) expressed on the T cell surface that defines an alternative activation signal for human T lymphocytes. It is absent from or present in only low amounts on resting T cells but it is expressed strongly after activation. Crosslinking of CD26/Tp103 via the monoclonal antibody CB.1 triggers functional activities in preactivated T cells. To study the molecular requirements for T cell activation via CD26 we transfected a cDNA encoding CD26 into several CD26-negative cells. In Jurkat T cell leukemia cells that normally do not express the CD26 antigen, the transfected CD26 molecule is functional because the monoclonal antibody CB.1 induces an increase of cytosolic Ca2+ concentration and IL-2 production. For this stimulatory effect a crosslinking of the monoclonal antibody CB.1 is necessary. After modulation of the TCR/CD3 complex the transfected Jurkat cells were insensitive to triggering via CD26. Moreover, a CD26-transfected TCR-negative variant of Jurkat cells did not respond to CD26 triggering despite high levels of expression of the molecule on their surface. These data demonstrate that the function of CD26/Tp103 is dependent on the expression of the T cell receptor complex. In search of a physiological function of CD26 we found a costimulatory effect of mAb CB.1 in combination with the nonstimulatory anti-CD3 antibody BMA030 and an additive effect in the response to the superantigen staphylococcal enterotoxin E. Transfected Jurkat cells, however, did not show a reproducibly enhanced responsiveness to the superantigen compared to that of untransfected cells. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:249 / 260
页数:12
相关论文
共 41 条
[31]   INTERLEUKIN-2 PRODUCTION BY HUMAN LYMPHOCYTES-T IDENTIFIED BY ANTIBODIES TO DIPEPTIDYL PEPTIDASE-IV [J].
SCHOLZ, W ;
MENTLEIN, R ;
HEYMANN, E ;
FELLER, AC ;
ULMER, AJ ;
FLAD, HD .
CELLULAR IMMUNOLOGY, 1985, 93 (01) :199-211
[32]   THE ROLE OF DIPEPTIDYL PEPTIDASE-IV IN HUMAN LYMPHOCYTE-T ACTIVATION - INHIBITORS AND ANTIBODIES AGAINST DIPEPTIDYL PEPTIDASE-IV SUPPRESS LYMPHOCYTE-PROLIFERATION AND IMMUNOGLOBULIN-SYNTHESIS INVITRO [J].
SCHON, E ;
JAHN, S ;
KIESSIG, ST ;
DEMUTH, HU ;
NEUBERT, K ;
BARTH, A ;
VONBAEHR, R ;
ANSORGE, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (12) :1821-1826
[33]   DIPEPTIDYL PEPTIDASE-IV IN HUMAN LYMPHOCYTE-T - IMPAIRED INDUCTION OF INTERLEUKIN-2 AND GAMMA-INTERFERON DUE TO SPECIFIC-INHIBITION OF DIPEPTIDYL PEPTIDASE-IV [J].
SCHON, E ;
DEMUTH, HU ;
EICHMANN, E ;
HORST, HJ ;
KORNER, IJ ;
KOPP, J ;
MATTERN, T ;
NEUBERT, K ;
NOLL, F ;
ULMER, AJ ;
BARTH, A ;
ANSORGE, S .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1989, 29 (02) :127-132
[34]  
SCHREZENMEIER H, 1988, J IMMUNOL, V141, P398
[35]   MOLECULAR-CLONING OF THE CD2 ANTIGEN, THE T-CELL ERYTHROCYTE RECEPTOR, BY A RAPID IMMUNOSELECTION PROCEDURE [J].
SEED, B ;
ARUFFO, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) :3365-3369
[37]  
STEIN HR, 1990, LEUKOCYTE TYPING, V4, P412
[38]  
TORIMOTO Y, 1991, J IMMUNOL, V147, P2514
[39]  
VIVIER I, 1991, J IMMUNOL, V147, P447
[40]  
WALTER R, 1980, MOL CELL BIOCHEM, V30, P111